Orchid Pharma to foray into B2C business
Chennai-based drug maker Orchid Pharma plans tie-up with large companies to market B2C products in the US29-08-2023
29-08-2023
Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Investor Presentation
Transcript of Earning Call for quarter ended June 30, 2023.21-08-2023
Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio Recording of the Investor Call14-08-2023
Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation14-08-2023
Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Monitoring Agency Report for quarter ended June 30, 202314-08-2023
Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Announcement under Regulation 30 of SEBI (LODR) Regulation, 2015 - Newspaper Publication12-08-2023
Orchid Pharma Ltd - 524372 - Board Meeting Outcome for Outcome Of Board Meeting - Approval Of Unaudited (Standalone & Consolidated) Financial Results For The Quarter Ended June 30. 2023
Outcome of Board Meeting - Approval of Unaudited (Standalone & Consolidated) Financial Results for the quarter ended June 30. 202310-08-2023
Orchid Pharma Ltd - 524372 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Voting Results along with Scrutinizers Report for the 30th Annual General Meeting of the Company10-08-2023
Orchid Pharma Ltd - 524372 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceeding of 30th Annual General Meeting of the Company09-08-2023